Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.71 |
| ▸ | ITGA2B | P08514 | 20/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7213411 | 0.91 | ITGB3 (0.59) | ITGB3ITGA2B | |
| SCHEMBL7748060 | 0.83 | ITGB3 (1.00) | ITGB3ITGA2B | |
| SCHEMBL7847593 | 0.77 | ITGB3 (0.44) | ITGB3ITGA2B | |
| SCHEMBL7090791 | 0.77 | ITGB3 (0.89) | ITGB3ITGA2B | |
| SCHEMBL7748714 | 0.76 | ITGB3 (0.63) | ITGB3ITGA2B | |
| SCHEMBL21706030 | 0.75 | ITGB3 (0.75) | ITGB3ITGA2B | |
| SCHEMBL7373273 | 0.75 | F2 (0.45) | ITGB3ITGA2B | |
| SCHEMBL7213400 | 0.74 | ITGB3 (1.00) | ITGB3ITGA2B | |
| SCHEMBL7700495 | 0.74 | ITGB3 (0.47) | ITGB3ITGA2B | |
| SCHEMBL7700493 | 0.74 | ITGB3 (0.47) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3554391-B1 | VASCULAR OCCLUSION DEVICES | OKAMI MEDICAL INC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20250186049-A1 | FILAMENTARY DEVICES FOR TREATMENT OF VASCULAR DEFECTS | MICROVENTION INC (US) | 2025-06-12 | — | — | US | disclosed |
| US-12318091-B2 | Filamentary devices for treatment of vascular defects | MICROVENTION, INC. (US) | 2025-06-03 | — | — | US | disclosed |
| US-20250152177-A1 | FILAMENTARY DEVICES FOR TREATMENT OF VASCULAR DEFECTS | MICROVENTION INC (US) | 2025-05-15 | — | — | US | disclosed |
| US-20250143709-A1 | DEVICES FOR THERAPEUTIC VASCULAR PROCEDURES | MICROVENTION INC (US) | 2025-05-08 | — | — | US | disclosed |
| US-20250143707-A1 | METHODS AND DEVICES FOR TREATMENT OF VASCULAR DEFECTS | MICROVENTION INC (US) | 2025-05-08 | — | — | US | disclosed |
| US-12226102-B2 | Devices for therapeutic vascular procedures | MICROVENTION, INC. (US) | 2025-02-18 | — | — | US | disclosed |
| US-20250025181-A1 | FILAMENTARY DEVICES FOR TREATMENT OF VASCULAR DEFECTS | MICROVENTION INC (US) | 2025-01-23 | — | — | US | disclosed |
| US-20240398416-A1 | FILAMENTARY DEVICES FOR TREATMENT OF VASCULAR DEFECTS | MICROVENTION INC (US) | 2024-12-05 | — | — | US | disclosed |
| US-12096940-B2 | Filamentary devices for treatment of vascular defects | MICROVENTION, INC. (US) | 2024-09-24 | — | — | US | disclosed |
| EP-3171793-B1 | FILAMENTARY DEVICES FOR TREATMENT OF VASCULAR DEFECTS | MICROVENTION INC (US) | 2024-07-24 | — | — | EP | disclosed |
| CN-111248966-B | Filiform device for treating vascular defects | 后续医疗股份有限公司 | 2023-09-12 | — | — | CN | disclosed |
| US-20230270441-A1 | DEVICES FOR THERAPEUTIC VASCULAR PROCEDURES | MICROVENTION INC (US) | 2023-08-31 | — | — | US | disclosed |
| US-11723667-B2 | Filamentary devices for treatment of vascular defects | MICROVENTION, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| US-11678886-B2 | Devices for therapeutic vascular procedures | MICROVENTION, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| CN-110573092-B | Vasoocclusive devices and methods | 因赛普特斯医学有限责任公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20230107778-A1 | METHODS AND DEVICES FOR TREATMENT OF VASCULAR DEFECTS | MICROVENTION, INC. | 2023-04-06 | — | — | US | disclosed |
| US-20220117607-A1 | METHODS AND DEVICES FOR TREATMENT OF VASCULAR DEFECTS | MICROVENTION, INC. | 2022-04-21 | — | — | US | disclosed |
| US-11304701-B2 | Vascular occlusion devices and methods | INCEPTUS MEDICAL, LLC (US) | 2022-04-19 | — | — | US | disclosed |
| US-20220031335-A1 | VASCULAR OCCLUSION DEVICES AND METHODS | TRINITY CAPITAL INC., AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT | 2022-02-03 | — | — | US | disclosed |